Walleye Capital’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-51,272
Closed -$4.36M 1288
2020
Q3
$4.36M Buy
+51,272
New +$2.59M 0.49% 28

Walleye Capital's IMMU Position: Q4 2020 in Review

Walleye Capital sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 51,272 shares — an estimated $4.36M sold.

Walleye Capital first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $4.36M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Walleye Capital reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Walleye Capital sold 51,272 Immunomedics Inc shares in Q4 2020, an estimated $4.36M.
  • Walleye Capital first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Walleye Capital's Immunomedics Inc position peaked at $4.36M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Walleye Capital's 13F filing for Q4 2020, filed 16 Feb 2021.